These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4553078)

  • 1. Suppression of chemotatic activity of human neutrophils by streptolysin O.
    Andersen BR; Van Epps DE
    J Infect Dis; 1972 Apr; 125(4):353-9. PubMed ID: 4553078
    [No Abstract]   [Full Text] [Related]  

  • 2. Streptolysin O inhibition of neutrophil chemotaxis and mobility: nonimmune phenomenon with species specificity.
    Van Epps DE; Andersen BR
    Infect Immun; 1974 Jan; 9(1):27-33. PubMed ID: 4128632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large scale preparation of oxidized streptolysin O using molecular filtration.
    Gazzei G; Palei F; Benanchi PL; Fabbiani S; Antoni G; Neri P
    Experientia; 1982 May; 38(5):637-8. PubMed ID: 7047207
    [No Abstract]   [Full Text] [Related]  

  • 4. Kinetic study on streptolysin O.
    Kanbayashi Y; Hotta M; Koyama J
    J Biochem; 1972 Feb; 71(2):227-37. PubMed ID: 4552642
    [No Abstract]   [Full Text] [Related]  

  • 5. Production, purification, and assay of streptolysin S.
    Alouf JE; Loridan C
    Methods Enzymol; 1988; 165():59-64. PubMed ID: 3068490
    [No Abstract]   [Full Text] [Related]  

  • 6. Lymphocyte stimulation with streptolysin O preparations. I. Purification of streptolysin O and the existence of two stimulants for rabbit lymphocytes cultured in vitro.
    Abe Y
    Jpn J Exp Med; 1971 Oct; 41(5):431-42. PubMed ID: 5316309
    [No Abstract]   [Full Text] [Related]  

  • 7. Oxygen-stable hemolysins of group A streptococci. 8. Leukotoxic and antiphagocytic effects of streptolysins S and O.
    Ofek I; Bergner-Rabinowitz S; Ginsburg I
    Infect Immun; 1972 Oct; 6(4):459-64. PubMed ID: 4634952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of streptolysin O from Streptococcus pyogenes.
    Canalias F; Viver J; Beleta J; Gonzalez-Sastre F; Javier Gella F
    Int J Biochem; 1992 Jul; 24(7):1073-9. PubMed ID: 1397501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Titration of antistreptolysin O through streptolysin haemolytic effect inhibition (author's transl)].
    Bozdĕch V; Skácel P; Dosková M; Riedl O
    Cas Lek Cesk; 1981 Apr; 120(17):500-6. PubMed ID: 7237495
    [No Abstract]   [Full Text] [Related]  

  • 10. An immunodiffusion micromethod for comparative analysis of the hemolytic activity and antigenicity of streptolysin O.
    Holm SE; Möller A
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1971; 79(1):73-8. PubMed ID: 4995775
    [No Abstract]   [Full Text] [Related]  

  • 11. Streptococcus pyogenes streptolysin O as a cause of false-positive CAMP reactions.
    Tapsall JW; Phillips EA
    J Clin Microbiol; 1984 Apr; 19(4):534-7. PubMed ID: 6371051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of RNA-core induced streptolysin S, and isolation and haemolytic characteristics of the carrier-free toxin.
    Loridan C; Alouf JE
    J Gen Microbiol; 1986 Feb; 132(2):307-15. PubMed ID: 3519856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progressive inactivation of streptolysin O incubated alone or in the presence of beta-lipoprotein. Antagonistic effect of albumin and a reducing agent].
    Badin J; Denne MA
    Ann Biol Clin (Paris); 1972; 30(5):433-8. PubMed ID: 4639764
    [No Abstract]   [Full Text] [Related]  

  • 14. Characteristics of streptolysin O action.
    Oberley TD; Duncan JL
    Infect Immun; 1971 Dec; 4(6):683-7. PubMed ID: 4949508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production, purification, and assay of streptolysin O.
    Alouf JE; Geoffroy C
    Methods Enzymol; 1988; 165():52-9. PubMed ID: 3231118
    [No Abstract]   [Full Text] [Related]  

  • 16. Activation of human polymorphonuclear neutrophils by streptolysin O from Streptococcus pyogenes leads to the release of proinflammatory mediators.
    Nilsson M; Sørensen OE; Mörgelin M; Weineisen M; Sjöbring U; Herwald H
    Thromb Haemost; 2006 Jun; 95(6):982-90. PubMed ID: 16732377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of hemolytic efficiency and isoelectric point of streptolysin O.
    Suzuki J; Kobayashi S; Kagaya K; Fukazawa Y
    Infect Immun; 1988 Sep; 56(9):2474-8. PubMed ID: 3045002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some factors influencing the effect of cholesterol on streptolysin O activity.
    Watson KC; Rose TP; Kerr EJ
    J Clin Pathol; 1972 Oct; 25(10):885-91. PubMed ID: 4646300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of streptolysin O hemolysis: kinetics of hemoglobin and 86rubidium release.
    Duncan JL
    Infect Immun; 1974 Jun; 9(6):1022-7. PubMed ID: 4598253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte transformation with streptolysin S preparations and inhibition of streptolysin S by serum in rheumatic fever and other rheumatic diseases.
    Cuppari G; Quagliata F; Ieri A; Taranta A
    J Lab Clin Med; 1972 Aug; 80(2):165-78. PubMed ID: 4537885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.